Effect of HIPEC on Peritoneal Carcinomatosis in Rats
Author Information
Author(s): Pelz Joerg OW, Doerfer J, Dimmler A, Hohenberger W, Meyer T
Primary Institution: University of Erlangen-Nuremberg, Germany
Hypothesis
The study aims to evaluate the tumor response of peritoneal carcinomatosis in tumor-bearing rats treated with HIPEC.
Conclusion
HIPEC is an effective treatment for peritoneal carcinomatosis in this animal model, significantly reducing tumor spread.
Supporting Evidence
- All control animals developed extensive intraperitoneal tumor growth.
- Histological tumor load was significantly reduced in groups treated with HIPEC.
- In group IV, no macroscopic tumors were found in 2 rats.
Takeaway
HIPEC helps shrink tumors in rats with cancer in their bellies, making them smaller and less spread out.
Methodology
The study used a rat model with implanted colon carcinoma cells, randomized into five treatment groups, and evaluated tumor response after HIPEC.
Limitations
The study was conducted in an animal model, which may not fully replicate human responses.
Participant Demographics
30 inbred male pathogen-free WAG rats, aged and weighing 200 to 240 g.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website